Are you speaking from advanced knowledge? My understanding is that you still have to find a relatively stable binding site that doesn't have a high degree of similarity to human cell markers. So the mRNA technique is a great path from the identification of a binding site to a vaccine, with the difficulty of that identification not being particularly predictable.